A Novel Treatment With Obinutuzumab-Chlorambucil in a Patient With B-Cell Prolymphocytic Leukemia: A Case Report and Review of the Literature

We report the case of a patient with B-cell prolymphocytic leukemia who was successfully treated with the novel humanized monoclonal antibody obinutuzumab. This patient was previously treated with the combination of rituximab and bendamustine and had recurrent infusion reactions. Her treatment with...

Descripción completa

Detalles Bibliográficos
Autores principales: Hew, Jason, Pham, Dat, Matthews Hew, Trevanne, Minocha, Vinay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6050796/
https://www.ncbi.nlm.nih.gov/pubmed/30038912
http://dx.doi.org/10.1177/2324709618788674

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6050796/
https://www.ncbi.nlm.nih.gov/pubmed/30038912
http://dx.doi.org/10.1177/2324709618788674

Ejemplares similares